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The NADPH oxidase NOX2 as a novel biomarker for
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L Trabace1
Recent evidence points towards a role of oxidative stress in suicidality. However, few studies were carried out on the sources of
reactive oxygen species (ROS) in subjects with suicidal behaviour. We have previously demonstrated that the NADPH oxidase
NOX2-derived oxidative stress has a major role in the development of neuropathological alterations observed in an animal model
of psychosis. Here, we investigated the possible increase in NOX2 in post mortem brain samples of subjects who died by asphyctic
suicide (AS) compared with controls (CTRL) and subjects who died by non-suicidal asphyxia (NSA). We found that NOX2 expression
was signiﬁcantly higher in the cortex of AS subjects than in the other two experimental groups. NOX2 immunostaining was mainly
detected in GABAergic neurons, with a minor presence of NOX2-positive-stained cells in glutamatergic and dopaminergic neurons,
as well as astrocytes and microglia. A sustained increase in the expression of 8-hydroxy-2’-deoxyguanosine, an indirect marker of
oxidative stress, was also detected in the cortex of AS subjects, compared with CTRL and NSA subjects. A signiﬁcant elevation in
cortical interleukin-6 immunoreactivity in AS subjects suggested an involvement of cytokine-associated molecular pathways in
NOX2 elevations. Our results suggest that the increase in NOX2-derived oxidative stress in the brain might be involved in the
neuropathological pathways leading to suicidal behaviour. These results may open innovative insights in the identiﬁcation of new
pathogenetic and necroscopic biomarkers, predictive for suicidality and potentially useful for suicide prevention.
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INTRODUCTION
Psychiatric disorders, such as depression, bipolar disorders and
psychosis, are associated with high risk of suicide.1 In modern
societies, suicide represents a major public health problem and, in
particular, suicide by asphyxia appears to be the most common
suicidal modality in European patients.2–4 Thus, violent asphyxia
remains a common cause of death in the practice of forensic
pathologists.5 However, current knowledge on the neurobiological
factors associated with suicide risk is still poor. A number of
reports pointed out that affective illness and psychosocial distress
could represent major risk factors for suicidal behaviour, and
several studies have described biochemical changes in post
mortem brain samples of suicidal subjects.6 Although a large
amount of data focus on forensic and legal aspects of suicide, few
investigations have been conducted to identify molecular path-
ways leading to suicidality. Increasing evidence shows a possible
contribution of brain oxidative stress and increased reactive
oxygen species (ROS) production in the central nervous system
(CNS) in the development of suicidal behaviour.7 Possible sources
of ROS include the NADPH oxidase NOX2 enzyme, which is a
protein that transfers electrons across biological membranes to
produce superoxide. This enzyme is constitutively expressed in the
CNS and is a major generator of ROS in several pathological
conditions, from psychiatric to neurodegenerative diseases.8 In
particular, we recently demonstrated that early NOX2 increase in
speciﬁc brain areas contributes to the development of neuro-
pathological alterations observed in non-pharmacologic and
pharmacologic rodent models of psychosis, such as the social
isolation and the ketamine model, respectively.9–11
Multiple studies have shown that high circulating interleukin-6
(IL-6) is positively associated with enhanced risk of disease and
disability development.12 In particular, cerebral IL-6 expression has
been shown to mediate alterations of CNS functioning, including
modulation of glutamatergic neurotransmission.13 In the ketamine
rodent model of psychosis, administration of this dissociative
anaesthetic drug to young mice increased expression of IL-6 in the
brain, as well as of the NADPH oxidase NOX2.14
Collections of post mortem brain samples and brain banking
represent very useful tools for improving our understanding of
molecular mechanisms associated with neuropsychiatric diseases,
for identifying new diagnostic targets and for developing new
therapeutic and prevention strategies.15
Thus, the main aim of this study was to evaluate the possible
role of NOX2-derived oxidative stress in suicidal behaviour. To this
purpose, we analysed a total of 42 human autoptic brain
specimens divided into three different experimental groups:
subjects who died by asphyctic suicide (n= 26; AS), subjects
who died by non-suicidal asphyxia (n= 6; NSA) and subjects who
died by other causes of death (neither suicide nor NSA) as controls
(CTRL; n= 10). Post mortem brain samples of these subjects were
analysed for expression of NOX2 and other markers of oxidative
stress with immunohistochemistry. NOX2 expression in cellular
brain subpopulations (neurons, microglia and astrocytes) was also
evaluated. Finally, the possible involvement of IL-6-associated
pathways in NOX2 elevations was investigated.
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MATERIALS AND METHODS
Post mortem sample recruitment
Autopsy records of autopsies performed at the Section of Legal Medicine,
Department of Clinical and Experimental Medicine, University of Foggia,
Italy, from 2001 to 2014 were evaluated. A total number of 26 post mortem
brain samples of AS subjects (17 cases of hanging and 9 cases of
strangulation), 10 post mortem brain samples of CTRL subjects (died
following road accidents without brain injury or cardiac sudden deaths)
and 6 post mortem brain samples of NSA subjects (1 case of smothering, 1
case of choking, 1 case of positional asphyxia and 3 cases of traumatic
asphyxia by chest compression) were recruited. Exclusion criteria included
deaths following accidental poisoning, organophosphate-induced
asphyxia, presence of severe infectious diseases (such as AIDS) and
recreational abuse of ketamine. Toxicological analyses for the most
common drugs of abuse (cocaine, heroin, amphetamine, methadone and
cannabinoids) were negative for all subjects included in the study.
Sociodemographic distribution
Sociodemographic distribution of subjects included in the study is
reported in Table 1.
Technical details
For all subjects included in the study, autopsies were performed between
24 and 48 h after death. To avoid the progression of transformative
phenomena, bodies were kept in cold storage room (−5 °C) until the
performance of autopsy.
Histological and immunohistochemical study
A routine microscopic histopathological analysis was performed on brain
samples, collected during autopsies. In particular, specimens derived from
the frontal cortex were processed and stained with haematoxylin–eosin.
Expression of NOX2 enzyme and markers of oxidative stress was
evaluated using anti-Nox 2 (Santa Cruz Biotechnology, Santa Cruz, CA,
USA) and anti-8-hydroxy-2’-deoxyguanosine (8-OHdG) antibodies (JaICA,
Shizuoka, Japan). Neuroinﬂammation was investigated using anti-IL-6
(Santa Cruz Biotechnology), anti-TNF (tumour necrosis factor)-α (Santa Cruz
Biotechnology), anti-IL-10 (Peprotec, London, UK) and anti-IL-1 beta (Santa
Cruz Biotechnology) antibodies.
Brieﬂy, 4-μm-thick parafﬁn sections mounted on slides covered with 3-
aminopropyltriethoxysilane (Fluka, Buchs, Switzerland) were used. Proteo-
lytic enzyme (Dako, Copenhagen, Denmark) pretreatment at 20 °C (for anti-
IL-6 and anti-IL-10) or microwave pretreatment in 0.25 M EDTA buffer (for
anti-IL1β) and in 0.1 M citric acid buffer (for anti-TNFα, anti-NOX2 and anti-
Table 1. Sociodemographic distribution
Characteristics Controls (n= 10) Non-suicidal asphyxia (n=6) Asphyctic suicide (n= 26)
Gender
Male 8 2 21
Female 2 4 5
Age group
18–40 3 2 18
40–70 6 1 4
470 1 3 4
Race
Caucasian 10 6 26
Black 0 0 0
Asian 0 0 0
Mixed 0 0 0
Marital status
Single 2 0 5
Stable relationship 7 4 9
Divorced/separated 1 0 3
Widow 0 1 1
Not known 0 1 8
Psychiatric anamnesis
Negative/not known 10 6 18
Positive 0 0 8
1 Delirium of persecution
1 Behaviour disorders
3 Aspeciﬁc psychiatric disorder
3 Alcohol addiction
Other stressful conditions
Negative/not known 10 6 9
Positive 0 0 17
4 Detention
1 Pregnancy
6 Recent outage of a romantic relationship
2 Neoplastic diseases
2 Recent lost of job
2 Homicide-suicide
Medication
Not known 10 6 25
Psychiatric medication 0 0 1
Citalopram 20 mg/die
Haloperidol 30 mg/die
Promazine 50 mg according to needs
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8-OHdG) were performed to facilitate antigen retrieval and to increase
membrane permeability. Dilutions of primary antibodies were as follows:
1:10 for 8-OHdG, 1:50 for NOX2, 1:600 for TNFα, 1:4000 for IL-1 beta and
1:2000 for IL-6 and IL-10. Incubation time was 120 min at room
temperature. The used detection system consisted of a reﬁned avidin–
biotin technique in which a biotinylated secondary antibody reacted with
several peroxidase-conjugated streptavidin molecules. The peroxidase–
avidin/biotin complex was visualised using DAB (3,3-diaminobenzidinete-
trahydrochloride hydrate) with a brown reaction. Sections were ﬁnally
counterstained with Mayer’s haematoxylin.
To identify the cellular subtype involved in NOX2 increase, double
immunohistochemistry was performed using various peroxidase substrates
with different colours: Vector NovaRED (red), Vector VIP (purple), Vector SG
(blue/grey) and DAB (brown; Vector, Burlingame, CA, USA). Brain tissue
pretreatment and NOX2 detection were conducted as previously
described,9–11 and the peroxidase–avidin/biotin complex was visualised
using Vector SG with a blue/grey reaction. Slices were incubated with the
following primary antibodies: Neun (Abcam, Cambridge, UK) 1:1000 ratio,
glial ﬁbrillary acidic protein (GFAP) (Santa Cruz Biotechnology) 1:300 ratio,
MAC387 (Santa Cruz Biotechnology) 1:200 ratio, GAD67 (Abcam) 1:2000
ratio, VGLUT1 (Abcam) 1:500 ratio and DT1 (Abcam) 1:100 ratio. After the
incubation with the detection system, the peroxidase–avidin/biotin
complex was visualised using Vector NovaRED (red reaction) for MAC387
and GAD67, Vector VIP (purple reaction) for Neun and GFAP, and DAB
(brown reaction) for DT1 and VGLUT1. Sections were counterstained with
methyl green, dehydrated, coverslipped and observed in a Leica DM6000
optical microscope (Leica, Cambridge, UK).
Quantiﬁcation of NOX2, 8-OHdG, IL-6, TNFα, IL-10 and IL-1 beta-positive-
stained cells was performed using the ImageJ software (imagej.nih.gov/ij/)
and expressed as number of positive stained cells/analysed area.
Statistical analysis
Data were analysed using the GraphPad Prism 5 software for Windows (La
Jolla, CA, USA). Data were checked for normality. Parametric data were
analysed by one-way analysis of variance (ANOVA), followed by Tukey's
post hoc test. Non-parametric data were analysed by Kruskal–Wallis
followed by Dunn’s multiple comparisons test. For all tests, a P-
valueo0.05 was considered statistically signiﬁcant. Results are expressed
as means± s.e.m. in graphs. s.d.'s are indicated in the Results section.
RESULTS
Increase in NOX2 and 8-OHdG immunostaining in the cortex of AS
subjects
In order to investigate whether NOX2-derived oxidative stress
might be involved in deaths by suicide, we performed
immunohistochemical analysis for NOX2, focusing on the cortex
of AS subjects, compared with CTRL and NAS subjects. NOX2
immunostaining was under detection levels in CTRL subjects.
Whereas the presence of only few NOX2-positive-stained cells was
observed in NSA subjects, a signiﬁcant increase in the number of
NOX2-immunoreactive cells was detected in AS subjects
(Figures 1a–d, Kruskal–Wallis, followed by Dunn’s multiple
comparisons test, ***Po0.001; *Po0.05, s.d. CTRL = 2.675; s.d.
NSA= 15.12; s.d. AS = 67.93). Contingency analysis revealed that
the increase in NOX2 expression observed in the cortex of AS
subjects was not correlated to gender (Supplementary Figure 1A;
Χ2, degree of freedom=0.62501; P= 0.4292) and age group
(Supplementary Figure 1B; Χ2, degree of freedom=3.0392;
P= 0.2188). Importantly, a concomitant signiﬁcant elevation of 8-
OHdG immunoreactivity was detected in the cortex of AS subjects,
with respect to CTRL and NSA subjects (Figures 1e–h, Kruskal–
Wallis followed by Dunn’s multiple comparisons test, ***Po0.001;
**Po0.01, s.d. CTRL = 3.502; s.d. NSA= 27.03; s.d. AS = 8. 682).
Increase in NOX2 immunostaining in GABAergic cortical neurons
of AS subjects
To evaluate which brain cellular subpopulation was involved in
NOX2 expression increase, we performed double immunohisto-
chemistry for NOX2 and Neun, an immunohistochemical marker
used for neuronal identiﬁcation, NOX2 and GFAP, an immunohis-
tochemical marker used to detect astrocytes, and NOX2 and
MAC387, used to identify microglia, in the cortex of AS subjects.
We found that NOX2 was mainly expressed in Neun-positive-
stained cells of AS subjects (Figures 2a and b), whereas a minor
percentage of NOX2/GFAP and NOX2/MAC387 co-staining was
detected in astrocytes (Figures 2c and d) and microglia,
respectively (Figures 2e and f). Thus, NOX2 was mainly increased
in cortical neurons of AS subjects.
To further investigate which neuronal subtype was speciﬁcally
involved in NOX2-increased expression, we performed double
immunohistochemistry for NOX2 and GAD67, an immunohisto-
chemical marker of GABAergic neurons, NOX2 and VGLUT1, an
immunohistochemical marker of glutamatergic neurons, and
NOX2 and DT1, an immunohistochemical marker of dopaminergic
neurons. Results showed the presence of NOX2 and GAD67 co-
staining in the cortex of AS subjects (Figures 3a and b). A very
weak co-staining for NOX2 and VGLUT1 (Figures 3c and d), as well
as for NOX2 and DT1 was detected (Figures 3e and f). Thus, results
Figure 1. Increase of NOX2 and 8-hydroxy-2’-deoxyguanosine (8-OHdG) immunostaining in the cortex of suicidal subjects. (a–c)
Representative images of NOX2 immunostaining in the cortex of controls (CTRL; a, n= 10), subjects who died by non-suicidal asphyxia
(NSA; b, n= 6) and by asphyctic suicide (AS; c, n= 26). (d) Quantiﬁcation of NOX2-positive-stained cells in the cortex of CTRL (n= 10), subjects
who died by NSA (n= 6) and by AS (n= 26). Kruskal–Wallis, followed by Dunn’s multiple comparisons test, ***Po0.001; *Po0.05; n.s.=not
signiﬁcant. (e–g) Representative images of 8-OHdG immunostaining in the cortex of CTRL (e, n= 10), subjects who died by NSA (f, n= 6) and
by AS (g, n= 26). (h) Quantiﬁcation of 8-OHdG-positive-stained cells in the cortex of CTRL (n= 10), subjects who died by NSA (n= 6) and by AS
(n= 26). Kruskal–Wallis, followed by Dunn’s multiple comparisons test, ***Po0.001; **Po0.01; n.s.=not signiﬁcant.
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indicated that increase in NOX2 expression mainly involves
cortical GABAergic neurons of AS subjects.
Increase in NOX2 in AS subjects is associated with IL-6 increase
To identify molecular mechanisms leading to the increase in NOX2
in the cortex of AS subjects, we investigated the possible
involvement of neuroinﬂammation and, in particular, alterations
of speciﬁc cytokines, such as IL-6, TNFα, IL-10 and IL-1 beta.
Whereas immunohistochemical analysis revealed the presence of
a weak IL-6 immunoreactivity in CTRL and NAS subjects, the
number of IL-6-positive-stained cells was dramatically increased in
AS subjects (Figures 4a–d, Kruskal–Wallis followed by Dunn’s
multiple comparisons test ***Po0.001; **Po0.01, s.d. CTRL =
8.208; s.d. NSA= 13.87; s.d. AS = 8.957). No signiﬁcant differences
in the number of TNFα (Figures 4e–h, one-way ANOVA followed
by Tukey's post hoc test, F = 1.372, s.d. CTRL = 8.959; s.d. NSA=
10.02; s.d. AS = 6.945), IL-10 (Figures 4i–l, one-way ANOVA
followed by Tukey's post hoc test, F = 0.929; s.d. CTRL = 2.404; s.d.
NSA= 2.338; s.d. AS = 1.975) and IL-1 beta (Figures 4m–p, one-way
ANOVA followed by Tukey's post hoc test, F = 0.1471; s.d. CTRL =
1.897; s.d. NSA= 3.488; s.d. AS = 3.659)-positive-stained cells were
detected between CTRL, NAS and AS subjects.
Figure 2. NOX2 immunostaining in neurons of suicidal subjects. (a, b) Representative images of double immunostaining for NOX2/Neun in the
cortex of suicidal subjects (n= 26) in bright ﬁeld (a) and contrast phase (b). (c, d). Representative images of double immunostaining for NOX2/
glial ﬁbrillary acidic protein (GFAP) in the cortex of suicidal subjects (n= 26) in bright ﬁeld (c) and contrast phase (d). (e, f) Representative
images of double immunostaining for NOX2/MAC387 in the cortex of suicidal subjects (n= 26) in bright ﬁeld (e) and contrast phase (f).
Figure 3. NOX2 immunostaining in cortical GABAergic neurons of suicidal subjects. (a, b) Representative images of double immunostaining
for NOX2/GAD67 in the cortex of suicidal subjects (n= 26) in bright ﬁeld (a) and contrast phase (b). (c, d). Representative images of double
immunostaining for NOX2/VGLUT1 in the cortex of a suicidal subjects (n= 26) in bright ﬁeld (c) and contrast phase (d). (e, f) Representative
images of double immunostaining for NOX2/DT1 in the cortex of a suicidal subjects (n= 26) in bright ﬁeld (e) and contrast phase (f).
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DISCUSSION
In this study, we evaluated a possible increase in NOX2-derived
oxidative stress in human post mortem brain samples of AS
subjects. We found that NOX2 expression was signiﬁcantly
increased in the cortex of AS subjects with respect to CTRL and
NSA subjects. NOX2 elevation was associated to a dramatic
increase in another marker of oxidative stress, the 8-OHdG.
Our results are in line with recent ﬁndings reporting oxidative
stress and lowered total antioxidant status in depressed subjects,
with a history of suicide attempts. Indeed, in a recent work, Vargas
et al.7 demonstrated an increased level of nitric oxide metabolites,
lipid hydroperoxides, malondialdehyde, as well as advanced
oxidation protein products and reduced plasmatic antioxidant
potential, in blood specimens of individuals with a positive
anamnesis for major depression and who attempted suicide. In
this context, nitric oxide-derived oxidative stress, related to a
polymorphism of the nitric oxide synthase 3 gene, has been
recently shown to be involved in the development of violent
suicidal behaviour in subjects suffering from bipolar disorders.16 In
addition, a genetic polymorphism in Glutathione-S-transferase,
leading to decreased antioxidant capacities, has been recently
associated with anxiety, mood disorders and increased risk of
suicide attempts.17 Some studies have also pointed towards a
possible effect of antioxidant compounds, such as selenium,18
vitamin E,19 vitamin D20 and vitamin A,21 in preventing or
decreasing suicidal behaviour, especially in depressed patients.
Interestingly, treatment with the glutathione precursor N-acet-
ylcysteine has been proposed for the prevention of suicidal
behaviour in psychiatric patients.22 With respect to the observed
NOX2 increase, a limitation of this study might be represented by
the small sample size of the NSA subjects. However, despite the
small sample size of this group, the low variability found within
the NSA subjects encouraged us to consider this result as a non-
Figure 4. Increase of NOX2 in suicidal subjects is associated with interleukin-6 (IL-6). (a–c) Representative images of IL-6 immunostaining in the
cortex of controls (CTRL; a, n= 10), subjects who died by non-suicidal asphyxia (NSA; b, n= 6) and by asphyctic suicide (AS; c, n= 26). (d)
Quantiﬁcation of IL-6-positive-stained cells in the cortex of CTRL (n= 10), subjects who died by NSA (n= 6) and by AS (n= 26). Kruskal–Wallis
followed by Dunn’s multiple comparisons test ***Po0.001; **Po0.01; n.s.=not signiﬁcant. (e–g) Representative images of tumour necrosis
factor alpha (TNFα) immunostaining in the cortex of CTRL (e, n= 10), subjects who died by NSA (f, n= 6) and by AS (g, n= 26). (h)
Quantiﬁcation of TNFα-positive-stained cells in the cortex of CTRL (n= 10), subjects who died by NSA (n= 6) and by AS (n= 26). One-way
analysis of variance (ANOVA) followed by Tukey's post hoc test, F= 1.372, n.s.=not signiﬁcant. (i–k) Representative images of IL-10
immunostaining in the cortex of CTRL (i, n= 10) and in subjects who died by NSA (j, n= 6) and by AS (k, n= 26). (l) Quantiﬁcation of IL-10-
positive-stained cells in the cortex of CTRL (n= 10), subjects who died by NSA (n= 6) and by AS (n= 26). One-way ANOVA followed by Tukey's
post hoc test, F= 0.9291, n.s.=not signiﬁcant. (m–o) Representative images of IL-1 beta immunostaining in the cortex of CTRL (m, n= 10),
subjects who died by NSA (n, n= 6) and by AS (o, n= 26). (p) Quantiﬁcation of IL-1 beta-positive-stained cells in the cortex of CTRL (n= 10),
subjects who died by NSA (n= 6) and by AS (n= 26). One-way ANOVA followed by Tukey's post hoc test, F= 0.1471, n.s.= not signiﬁcant.
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spurious ﬁnding. Moreover, given the features of this experimental
group, it was particularly difﬁcult to increase the sample size.
The role of the NADPH oxidase NOX2 in human pathologies has
been well documented, ranging from chronic granulomatous
disease,23–25 acute myocardial infarction26 to neurodegenerative
disorders.8 However, concerning the role of NOX2 in the
pathogenesis of psychiatric disorders, all available data have been
obtained in animal or cellular models. We have previously
demonstrated that an early NOX2 increase in speciﬁc brain areas
contributes to the development of neuropathological alterations
in non-pharmacologic and pharmacologic rodent models of
psychosis, such as the social isolation and ketamine models.9–11
However, although animal models of psychosis are undoubtedly
useful tools to reproduce some aspects of the human psychosis,
such as neurochemical and behavioural alterations reminiscent of
those observed in psychotic patients, they still remain far from the
complexity of the human pathology, especially in regard to
psychopathological, emotional and social aspects. To the best of
our knowledge, no evidence of the involvement of NOX2 in
human psychiatric diseases is actually available. Thus, our results
might be considered speciﬁc for suicidality, being, therefore, the
ﬁrst evidence of NOX2 increase in suicidal behaviour in humans.
A crucial ﬁnding of this study is that increased levels of NOX2
expression were mainly observed in cortical GABAergic neurons.
Interestingly, this neuronal subpopulation has been shown to be
exposed to several pathological alterations, such as loss of fast-
spiking parvalbumin-positive interneurons in animal models of
psychiatric disorders14,27 or changes in the density of calcium-
binding protein immunoreactivity in subjects suffering from
schizophrenia and bipolar disorders.28,29 An altered expression
of genes involved in GABAergic neurotransmission has also been
identiﬁed in the ventral prefrontal cortex of suicidal subjects with
or without major depression.30 In this line, Poulter et al.31 reported
gene-speciﬁc aberrations in DNA methylation of GABA-A receptor
α1 subunit promoter region, within the frontopolar cortex, in the
brains of suicidal/major depressed subjects. Interestingly, GABA
concentration in cerebrospinal ﬂuid appears to positively correlate
with impulsiveness and history of suicidal behaviour in personality
disordered subjects,32 although disinhibition is observed only in a
minority of cases. This may be consistent with observations that
high doses of benzodiazepines can lead to ‘behavioural disinhibi-
tion’, including suicide attempts, in human subjects.33
Another crucial aspect of this study is the signiﬁcant increase in
IL-6 expression in the cortex of AS subjects with respect to CTRL
and NAS subjects. Our data are in line with recent ﬁndings
showing IL-6 elevations in the cerebrospinal ﬂuid of depressed
suicide attempters and a pathological link between increased
levels of this cytokine and the severity of suicide ideation and
depressive symptoms.34 Importantly, IL-6 has been shown to be
necessary and sufﬁcient for NOX2 increase in the ketamine model
of schizophrenia,14 as well as the degeneration of forebrain
GABAergic interneurons through activation of the neuronal
NADPH oxidase.14,35 A possible molecular mechanism linking
NOX2 increase in GABAergic neurons, IL-6 elevations and suicidal
behaviour is represented in Figure 5 and described in details in its
legend. Although still speculative, this hypothetical mechanism is
supported by studies demonstrating increased glutamate levels36
and altered glutamate signalling37 in brains of suicidal patients
with mood disorders. In addition, microarray analysis in the
cerebral cortex of individuals who had suffered from major
depressive disorder and died by suicide demonstrated signiﬁcant
downregulation of the key members of the glutamate/neutral
amino-acid transporter protein family.38 Other evidence support-
ing this hypothesis deals with the fact that neurotoxic effects of
IL-6 appear to be mediated by its molecular interaction with the
N-methyl-D-aspartate receptor.39 A possible contribution of other
cellular populations, such as microglia, in NOX2-derived ROS
increase cannot be ruled out. Thus, we found a minor percentage
of NOX2/MAC387 co-staining in the cortex of AS subjects. This
result is in agreement with a study demonstrating that microglia is
directly involved in the development of pre-suicidal stress through
the release of different factors, which, in turn, appear to act on
noradrenergic and serotonergic neurotransmission.40 Further-
more, in a recent study of Schnieder et al., Authors demonstrated
greater density of ionised calcium-binding adapter molecule 1-
immunoreactive cells in the dorsal prefrontal white matter of
suicidal subjects.41
A possible involvement of other sources of oxidative stress in
the development of suicidal behaviour, such as mitochondria,
must be considered. Indeed, prevention of mitochondria-derived
ROS production by consumption of speciﬁc nutrients such as ω-3
fatty acids, vitamin C, zinc, members of the vitamin B family
(vitamin B12 and folic acid) and magnesium may help to prevent
Figure 5. Hypothetical molecular mechanism linking interleukin-6 (IL-6) increase to NOX2 elevation in suicidal behaviour. Under physiological
conditions, basal IL-6 release might be involved in the maintenance of physiological NOX2 expression in GABAergic neuron levels and ROS
production by interacting with the N-methyl-D-aspartate (NMDA) receptor placed on GABAergic neurons. This might permit the maintenance
of the physiological inhibitory tone of GABAergic neurons on glutamatergic ones to assure the release of basal glutamate levels and the
physiological excitatory tone, necessary to preserve a normal behaviour. Under pathological conditions, the increase in IL-6 levels might
mediate NOX2 elevations as well as NOX2-derived ROS production in GABAergic neurons, leading to an altered functioning of this neuronal
population, loss of inhibitory tone and, ﬁnally, increased glutamate release and excitotoxicity associated to altered behaviour and death by
suicide.
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the onset of mood disorders and suicidal behaviours in vulnerable
individuals.42
Subjects included in this study died by AS. Thus, a possible
question could arise: might this suicidal modality have a direct
impact on NADPH oxidase expression and NOX2-derived oxidative
stress production? To exclude the possibility that NOX2 increase
might be due to asphyxia and not to suicidal behaviour, we also
included, in our study, NAS subjects. Importantly, although a link
between asphyxia and the production of ROS, such as peroxyni-
trite, nitric oxide and nitrogen dioxide, has been demonstrated in
rodent models of perinatal and neonatal asphyxia,43 as well as
under this pathological condition in humans,44 we did not detect
any statistical differences between NAS subjects and CTRL. This
strongly argues in favour of a speciﬁc role of suicidal behaviour in
determining NOX2 and oxidative stress-marker elevation. The lack
of NOX2 elevation in the group of NAS subjects is also in line with
evidence demonstrating that hypoxia leads to the production of
nitric oxide and superoxide, essentially through the increased
expression and activation of cytoplasmic,45 as well as
mitochondrial,46 nitric oxide synthases and through the genera-
tion of superoxide anions, essentially by mitochondria.47 However,
a minor impact of asphyxia on NADPH oxidase expression and
activity cannot be totally excluded. Indeed, asphyxia has been
shown to induce an accumulation of neutrophils in asphyctic
organs, in particular the brain, associated with a production of ROS
via NADPH oxidase and of hypochlorous acid via
myeloperoxidase.48
Another important aspect that certainly requires attention is the
possible impact of medication on the observed NOX2 increase.
Thus, within AS subjects, one was medicated with citalopram,
haloperidol and promazine. To this regard, literature reported
some data on the possible link existing between peripheral side
effects of this medication (such as erectile dysfunctions, pulmon-
ary hypertension, platelet hyperaggregability and agranulocytosis)
and increased NADPH oxidase-derived ROS production.49–51 To
the best of our knowledge, no data are actually available
describing a possible increase in NOX-derived brain oxidative
stress because of this medication. Thus, although it has been
shown that haloperidol induces oxidative stress in the rat brain,
this has been mainly attributed to mitochondrial superoxide
generation and production of nitric oxide by nitric oxide synthase
enzymes.52–55 However, a possible effect of these pharmacological
compounds on the observed increased in NOX2 cannot be totally
excluded.
Measuring NOX-enzyme activity is a crucial step in under-
standing their physiological and pathological roles. Thus, a
limitation of this study is certainly represented by the lack of
data concerning NOX2 activity in these human brain samples. It
appears to us particularly important to underline that efﬁcient and
reliable methods to directly measure NOX activity actually
represent the major breakthrough in the ﬁeld of NOX and
oxidative stress.56 Thus, the most commonly used methods could
lead to artefacts and misinterpretation. Novel methods for in vivo
measurement of NOX activity are emerging, and they appear to be
speciﬁc for the detection of oxidants in the brain.57
A limiting step in suicide prediction and prevention is the lack
of objective and reliable predictors.58 Interestingly, in this study,
we suggest the NADPH oxidase NOX2 as a novel biomarker for
suicide and suicidal behaviour. In this context, it seems important
to highlight that biomarkers for suicidality have been studied
using principally blood samples of subjects with major mood
disorders or psychosis,59 two groups of psychiatric disorders in
which the role of NOX2-derived oxidative stress has been recently
well documented.9–11,60,61 Recently, Guintivano et al. also per-
formed a genome-wide DNA methylation proﬁling of three
independent data sets of post-mortem brains of suicidal subjects,
identifying signs of increased methylation in one particular gene,
SKA2.62 Intriguingly, the protein derived from this gene mainly acts
via a ‘redox-sensitive’ pathway,63 being also implicated in
molecular mechanisms of protection against ROS-derived
neurotoxicity.64
Together with the possible use of NOX2 as a novel biomarker
for prediction and prevention of suicide, our study might be also
considered in the light of other possible clinical utilities. Thus, a
pathological link between increased oxidative stress in suicidal
subjects and alterations of brain morphology have been
reported65 and, interestingly, these brain alterations have been
identiﬁed with speciﬁc brain imaging techniques.66
CONCLUSIONS
The neurobiology of suicide is complex and remains still not
completely understood. Despite accumulating data exploring the
interaction between genetic, environmental, microstructural and
developmental factors involved in the suicide phenomenon, no
formal consensus exists in associating a neurobiological mechan-
ism to suicide. Post-mortem studies may be useful in characteriz-
ing the suicide proﬁle as suicide completers and suicide
attempters are only partially joined by common aetiological and
neurobiological mechanisms, and suicide completers are consid-
ered a more homogeneous group than suicide attempters.67
Deﬁning some potential biomarkers for suicidality could help in
determining modalities and circumstances of death that, in turn,
may improve our understanding of suicidal behaviour. Our results
strongly support the hypothesis that pharmacological targeting of
NOX2 might be crucial for the treatment and the reversion of
several behavioural alterations, such as suicide.
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